DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Adrianzen Herrera DA. et al.
Impressive and durable response to nivolumab in a patient with metastatic type 2 papillary renal cell carcinoma: On-label but without evidence.
Invest New Drugs 2017;
35: 665-668
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.